Antibodies to human papillomavirus 16 L1 virus-like particles as an independent prognostic marker in cervical cancer
✍ Scribed by Kurt Heim; Andreas Widschwendter; Gudrun Pirschner; Ute Wieland; Sabine Awerkiew; Neil D. Christensen; Anton Bergant; Christian Marth; Reinhard Höpfl
- Book ID
- 114487697
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 75 KB
- Volume
- 186
- Category
- Article
- ISSN
- 1097-6868
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Sexually transmitted genital human papillomavirus (HPY) infection, most often HPV 16, is considered the major etiologic determinant of cervical cancer. However, some studies have found relatively low prevalences of genital tract HPV DNA in some geographical areas, such as Greenland, that have high r
The aim of the study was to determine the prevalence of antibodies to human papillomavirus (HPV) types 16, 18, 31, 33, and 45 in woman in Cape Town with cervical intraepithelial neoplasia (CIN) (n = 95), cervical cancer (n = 40), female blood donors (n = 95) and children (n = 110). The enzyme-linked
## Abstract The serologic response against virus‐like particles (VLP) from 7 high risk genital papillomaviruses was investigated by ELISA in 147 Colombian women with invasive cervical cancer and 147 age‐matched cytologically normal and HPV‐DNA negative women. Anti‐VLP antibodies were detected in 82